Thomas Zimmerman

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Glycemic Control

Anti Inflammatory

Cardiovascular Disease

Top Venues

Journal of experimental pharmacology

Journal of inflammation research

This page only lists publications with an associated author ORCID identifier.

Publications

Heta Dinesh Bhatt, Lorne M Golub, Hsi-Ming Lee, Jihwan Kim, Thomas Zimmerman, Jie Deng, Houlin Hong, Francis Johnson, Ying Gu
Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss. Journal of inflammation research 16 (2023)
Heta Dinesh Bhatt, Lorne M Golub, Hsi-Ming Lee, Jihwan Kim, Thomas Zimmerman, Jie Deng, Houlin Hong, Francis Johnson, Ying Gu
Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss. Journal of inflammation research 16 (2023)
Heta Dinesh Bhatt, Steve A McClain, Hsi-Ming Lee, Thomas Zimmerman, Jie Deng, Francis Johnson, Ying Gu, Lorne M Golub
The Maximum-Tolerated Dose and Pharmacokinetics of a Novel Chemically Modified Curcumin in Rats. Journal of experimental pharmacology 14 (2022)
Jie Deng, Lorne M Golub, Hsi-Ming Lee, Michael C Lin, Heta Dinesh Bhatt, Hou-Lin Hong, Francis Johnson, Joseph Scaduto, Thomas Zimmerman, Ying Gu
Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs. Journal of experimental pharmacology 12 (2020)